nexopamil has been researched along with verapamil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirchengast, M; Lehmann, HD; Rübsamen, K | 1 |
| Braun, M; Hohlfeld, T; Schrör, K; Strobach, H | 1 |
| Boulanger, CM; Kirchengast, M; Park, SJ; Vanhoutte, PM | 1 |
| López-Novoa, JM; Montero, A; Reverte, M; Rodríguez-López, A | 1 |
| Boulanger, CM; Kirchengast, M; Lee, JJ; Park, SJ; Vanhoutte, PM | 1 |
| Hutter, JJ; Nearing, BD; Verrier, RL | 1 |
6 other study(ies) available for nexopamil and verapamil
| Article | Year |
|---|---|
Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Topics: Animals; Calcium; Coronary Circulation; Coronary Thrombosis; Dogs; Female; Gallopamil; Hemodynamics; Injections, Intravenous; Ketanserin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1993 |
Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.
Topics: Animals; Blood Platelets; Calcium Channel Blockers; Creatine Kinase; Diastole; Epoprostenol; Female; Granulocytes; Heart; Hemodynamics; Male; Methoxamine; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Serotonin Antagonists; Swine; Swine, Miniature; Thromboxane B2; Vasodilation; Verapamil | 1994 |
Effects of the combined 5-hydroxytryptamine2 receptor and Ca2+ channel antagonist LU49938 on the responsiveness of isolated porcine coronary arteries with and without endothelium.
Topics: Analysis of Variance; Animals; Calcium-Binding Proteins; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Serotonin; Serotonin Antagonists; Swine; Verapamil | 1994 |
The effect of LU-49938 (nexopamil) on the activation by serotonin of mesangial cells.
Topics: Animals; Cell Count; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Glomerular Mesangium; Ketanserin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Thymidine; Time Factors; Verapamil | 1995 |
The combined 5-HT2 receptor and calcium channel inhibitor LU49938 restores endothelium dependent responses in the regenerated endothelium of the porcine coronary artery.
Topics: Adrenergic alpha-Antagonists; Angioplasty, Balloon; Animals; Blood Platelets; Brimonidine Tartrate; Calcium Channel Blockers; Coronary Angiography; Coronary Vessels; Endothelins; Endothelium, Vascular; In Vitro Techniques; Male; Norepinephrine; Quinoxalines; Random Allocation; Regeneration; Serotonin; Serotonin Antagonists; Swine; Tunica Intima; Vasoconstriction; Verapamil | 1995 |
Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dogs; Electrocardiography; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Serotonin Antagonists; Verapamil | 1996 |